Provigate Begins Providing “glucoreview®” to Toyoda Gosei

2025.08.01

MEDIA

Supporting Health and Productivity Management Through Startup Collaboration

Provigate Inc. (Headquartered in Bunkyo-ku, Tokyo; CEO: Koshin Sekimizu) has commenced the provision of its innovative weekly blood glucose monitoring service, glucoreview®, to Toyoda Gosei Co., Ltd. (Headquartered in Kiyosu City, Aichi Prefecture; President & CEO: Katsumi Saito).

This initiative forms part of Toyoda Gosei’s new business development strategy and aims to accelerate the social implementation of health management support services through partnerships with healthcare startups.

The program enables participants to perform simple self-administered blood sampling at home and measure glycated albumin (GA) on a weekly basis. GA is a highly responsive biomarker that reflects average blood glucose levels over the past week, making it easier for individuals to understand the impact of their daily habits on blood glucose fluctuations. This regular feedback supports sustained improvements in health awareness and behavior.

Provigate will continue to assess the impact of this initiative and work toward expanding its reach to additional companies and health insurance associations. Through this effort, the company aims to contribute to the broader adoption of evidence-based Health and Productivity Management (H&PM) solutions.

For further information, please contact:
Provigate Inc.
https://provigate.com/en/contact/

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.